BioSpace News Archive

Drug Development

Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse

Allogene Therapeutics Inc. announced the initiation of the pivotal Phase 2 ALPHA3 trial evaluating the use of cemacabtagene ansegedleucel as part of the first line treatment regimen for newly diagnosed LBCL patients who are likely to relapse after standard 1L treatment and need further therapy.

June 20, 2024
·
10 min read
Business

GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions

GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.

June 20, 2024
·
2 min read
Business

BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts

BD (Becton, Dickinson and Company) announced today that it plans to host webcasts to discuss quarterly financial results on the following dates.

June 20, 2024
·
1 min read
Drug Development

Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide

Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose clinical trial with long-acting amylin analog petrelintide

June 20, 2024
·
9 min read
BioMidwest

United Digestive’s Dr. Justin J. Forde Introduces Advanced “Third-Space” Procedures at Northside Gwinnett Hospital

Dr. Justin J. Forde of United Digestive and Atlanta Gastroenterology Associates has successfully performed Northside Gwinnett Hospital’s first “third-space” gastrointestinal endoscopy procedures.

June 20, 2024
·
2 min read